Clementine, a Dutch startup, secured $2M to scale its AI hearing care platform. Its AI agent, Matthew, helps clinics convert leads and guides patients, tackling a global hearing loss treatment gap.
You know, the real challenge in healthcare isn't always the treatment itself—it's getting people to start the conversation. That's the gap a startup from Maastricht just landed $2 million to bridge.
Clementine, founded just this year, isn't building another generic chatbot. They've created something called Matthew, an AI hearing care agent designed specifically for clinics. Think of it less as a tool and more as a digital bridge, helping people take that first, often intimidating, step toward better hearing.
### The Funding and the Vision Behind It
The $2 million Seed round was led by Amsterdam's Healthy.Capital, an investor that knows its way around HealthTech. They've backed companies like Pharmi and OpenUp, so they spot potential. Their managing partner, Douwe Jippes, put it plainly: Clementine mixes deep industry know-how with an AI strategy built for global scale. They believe it can fundamentally change how people with hearing loss engage with care.
That's a big statement, but when you look at the problem, you start to see why. Founder and CEO Vince van de Weijer started the company, also known as ClementineAI, with a clear goal. They call themselves the world's first AI hearing activation platform, built from the ground up for this unique industry.
### How Matthew, the AI Agent, Actually Works
So, what does this platform do? It centers on Matthew, the AI agent. This isn't a simple FAQ bot. Matthew engages directly with potential patients, 24/7. No judgment, no waiting list. It answers questions, educates, and helps people overcome both emotional and practical barriers that stop them from seeking help.
- For clinics drowning in calls and admin, Matthew handles the initial conversation, turning inquiries into actual bookings.
- For patients, it means clear communication and a smoother path to better outcomes from the very first click.
"Clinics don't need more leads; they need better conversations at the right moment," says van de Weijer. "Matthew ensures no patient inquiry goes unanswered." That shift from quantity to quality is where the real magic happens.
### The Massive Problem They're Tackling
Let's talk scale for a second. The numbers Clementine cites are staggering. Hearing loss affects roughly 1.5 billion people globally. Here's the kicker—nearly 80% of those people never seek treatment. And for the ones who do? They typically wait over eight years before doing anything about it.
Eight years. That's a long time to miss out on conversations, music, connection. The barrier isn't just clinical; it's deeply psychological. Clementine's approach pairs AI with behavioral science to create a judgement-free, always-on starting point. It meets people where they are, long before they're ready to walk into a physical clinic.
### What's Next for Clementine?
This funding didn't come out of nowhere. It follows the company's recent expansion into North America via a partnership with Zoolstra, a marketing agency serving hearing clinics across the United States and Canada. They're already building their footprint.
The new capital has a clear purpose: to deepen the AI's capabilities and forge more partnerships. We're talking hearing clinics, optical retailers, other healthcare organizations—anywhere this digital front door makes sense.
It's a fascinating case study. A European startup, leveraging AI not for hype, but to solve a very human, very widespread problem of access and hesitation. They're not just selling software; they're trying to change a behavior that impacts millions. And now, with $2 million in backing, they're gearing up to scale that conversation globally.